| Synonyms: | |
| Status: | Approved (2020) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | L01EH03 |
| UNII: | 234248D0HH |
| InChI Key | SDEAXTCZPQIFQM-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C26H24N8O2 |
| Molecular Weight | 480.53 |
| AlogP | 5.09 |
| Hydrogen Bond Acceptor | 10.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 110.85 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 5.0 |
| Heavy Atoms | 36.0 |
| Primary Target | |
|---|---|
| erb-b2 receptor tyrosine kinase 2 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Breast Neoplasms | 4 | D001943 | ClinicalTrials |
| Breast Neoplasms | 4 | D001943 | ClinicalTrials |
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Breast Neoplasms | 4 | D001943 | FDA |
| Hemangiosarcoma | 2 | D006394 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | D015464 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 937263-43-9 |
| ChEMBL | CHEMBL3989868 |
| DrugBank | DB11652 |
| DrugCentral | 5389 |
| FDA SRS | 234248D0HH |
| Guide to Pharmacology | 9922 |
| PubChem | 51039094 |
| SureChEMBL | SCHEMBL1193050 |
| ZINC | ZINC000068250462 |